YOLFTbeta
30

Shanghai Xuerong Bio-Technology Co Ltd

300511 · SHE · Consumer Defensive / Farm Products

4.03CNY-0.08 (-1.95%)

Price History

Full chart

Market Stats

Previous Close4.11
Open4.09
Day Range4.02 – 4.14
52-Week Range4.70 – 8.50
Volume12.57M
Market Cap3.12B
P/E (TTM)18.04
Forward P/E0.00
EPS0.27
Dividend Yield0.00%
Beta0.47
50-Day Avg5.30
200-Day Avg6.24

About

Shanghai Xuerong Biotechnology Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, and sale of edible fungi in China and internationally. It offers enoki, white jade, crab, seafood, king oyster, shiitake, deer antler, and nameko mushrooms. The company was founded in 1995 and is based in Shanghai, China.

Company Details

  • SectorConsumer Defensive
  • IndustryFarm Products
  • CEOMr. Xueqiang Chen
  • Employees1.92K
  • HeadquartersNo. 1487 Huifeng West Road, Shanghai, China, 201401, China
  • Websitehttps://www.xuerong.com

Leadership

  • Mr. Xueqiang ChenCFO & Accounting Supervisor · b. 1970
  • Mr. Weidong ZhengExecutive VP & Non-Independent Director · b. 1970
  • Mr. Yongkang GuBoard Secretary · b. 1987
  • Mr. Yong LuDeputy General Manager · b. 1982

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue470.83M758.47M874.40M1.02B998.68M1.33B1.85B1.96B2.20B2.06B2.32B2.57B2.16B1.99B
Growth (%)-+61.09%+15.28%+16.54%-1.99%+33.20%+38.81%+6.39%+12.09%-6.33%+12.49%+10.55%-15.70%-8.09%
Cost of Revenue311.02M552.77M634.10M744.01M768.31M1.07B1.58B1.53B1.72B1.95B2.07B2.35B2.08B1.72B
Gross Profit---275.00M230.37M264.10M263.50M430.89M480.97M108.57M248.39M215.07M77.95M270.77M
Gross Margin---26.99%23.07%19.85%14.27%21.93%21.84%5.26%10.70%8.38%3.60%13.62%
Operating Expense---106.42M136.95M155.52M218.29M224.59M174.77M172.75M147.92M256.87M177.85M171.88M
Operating Income78.92M115.46M142.77M168.58M93.41M108.58M45.22M206.30M306.20M-64.18M100.47M-41.80M-99.89M98.89M
Operating Margin16.76%15.22%16.33%16.54%9.35%8.16%2.45%10.50%13.90%-3.11%4.33%-1.63%-4.62%4.98%
EBITDA-----353.90M478.59M570.34M615.79M38.41M53.75M221.43M-144.28M437.52M
EBITDA Margin-----26.60%25.92%29.03%27.96%1.86%2.32%8.63%-6.67%22.01%
Net Income---123.35M104.81M122.41M151.46M220.33M247.24M-308.90M-287.23M-188.06M-617.07M29.79M
Net Income Margin---12.10%10.49%9.20%8.20%11.22%11.23%-14.97%-12.38%-7.33%-28.54%1.50%
R&D8.01M3.73M3.47M7.08M2.82M7.08M11.43M10.93M11.85M13.56M7.49M6.84M3.46M3.34M
R&D as % of Total Revenue1.70%0.49%0.40%0.69%0.28%0.53%0.62%0.56%0.54%0.66%0.32%0.27%0.16%0.17%
Interest Expense00000078.83M78.68M71.66M77.11M92.96M88.77M98.21M60.68M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%4.27%4.01%3.25%3.74%4.01%3.46%4.54%3.05%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.41B1.46B1.55B1.77B2.46B3.84B3.89B3.84B4.56B4.34B4.07B4.60B3.85B3.60B
Total Liabilities1.03B1.03B1.02B1.13B1.17B2.42B2.32B2.10B2.54B2.69B2.45B3.17B3.03B2.09B
Total Equity369.52M427.31M522.81M634.91M1.28B1.39B1.57B1.74B2.03B1.67B1.74B1.55B938.63M1.61B
Cash51.02M67.41M-88.89M164.74M240.10M381.18M288.00M759.89M340.77M363.82M252.67M167.95M161.45M
Net Debt-----1.24B1.13B940.57M924.28M1.37B1.19B1.73B1.76B914.62M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow112.14M235.07M253.24M273.77M317.71M328.64M406.82M586.93M555.47M246.75M367.13M357.84M437.20M415.85M
Investing Cash Flow----260.03M-765.33M-1.09B-287.07M-239.01M-523.58M-597.38M----
Financing Cash Flow416.99M---15.68M489.23M847.95M8.34M-431.46M461.90M-68.50M----
Capital Expenditure559.93M198.39M163.01M283.78M695.20M1.18B442.23M312.38M482.79M639.87M319.47M1.10B327.46M79.59M
Free Cash Flow------872.87M-35.42M274.55M72.68M-393.13M47.66M-739.19M109.74M336.26M
Dividends Paid33.01M52.99M72.77M67.20M72.80M73.97M111.63M134.39M115.86M102.59M58.73M60.32M67.01M42.68M
FCF to OCF------265.60%-8.71%46.78%13.08%-159.32%12.98%-206.57%25.10%80.86%
Dividend Paid to FCF------8.47%-315.19%48.95%159.41%-26.10%123.22%-8.16%61.06%12.69%

Earnings

Report DateOct 26, 2016Mar 13, 2017Apr 25, 2017Aug 1, 2017Oct 29, 2017Feb 27, 2018Apr 11, 2018Aug 29, 2018Oct 19, 2018Feb 27, 2019Apr 25, 2019Aug 29, 2019Oct 29, 2019Feb 28, 2020Apr 25, 2020Aug 26, 2020Oct 12, 2020Dec 31, 2020Apr 9, 2021Aug 29, 2021Oct 28, 2021Dec 31, 2021Apr 26, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Apr 25, 2023Aug 29, 2023Oct 26, 2023Mar 28, 2024Apr 25, 2024Aug 28, 2024Oct 24, 2024Dec 31, 2024Apr 27, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------0.090.08-----------
EPS Actual0.040.170.11-0.020.100.090.26-0.190.240.040.32-0.05-0.010.260.40-0.030.140.070.22-0.41-0.11-0.43-0.45-0.340.21-0.600.44-0.36-0.34-0.120.01-0.30-0.04-0.910.01-0.180.060.140.27-0.24
Surprise----------------------------504.44%-525.00%-----------
TimingPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketAfter-hours-Pre-marketAfter-hoursPre-market-Pre-market---Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-Pre-market-----

Key Statistics & Ratios

Market Cap3.12B
Enterprise Value4.24B
Trailing P/E18.04
Forward P/E0.00
Price / Sales1.33
Price / Book1.93
EPS0.27
Book Value2.55
Revenue (TTM)2.35B
Gross Profit (TTM)374.01M
EBITDA512.68M
Profit Margin6.38%
Operating Margin-32.12%
Return on Equity11.04%
Return on Assets3.19%
Shares Outstanding640.85M
Shares Float514.41M
Beta0.47
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.12May 14, 2021
20201×
0.12Jun 11, 2020
20191×
0.12May 31, 2019
20181×
0.06Apr 23, 2018
20171×
0.05May 23, 2017
20161×
0.07Jul 14, 2016

Stock Splits

  • Apr 23, 20181.9:1
  • May 23, 201715:10